TEL: 202.772.5365
FAX: 202.218.0020

Email | Download vCard

Washington, D.C.
1300 I Street, N.W.
11th Floor East
Washington, DC 20005

Practices

T. Aidan Toombs

Print PDF

Patent Agent  

Mr. Aidan Toombs is a Patent Agent, in the Intellectual Property Practice Group in the firm's Washington, D.C. office.

Areas of Practice

Mr. Toombs' intellectual property practice includes patent drafting and prosecution, freedom to operate analyses and litigation support, especially in the life sciences field. Representative clients include Everett Laboratories, CDG Therapeutics, and Celera Genomics. He is also attending Georgetown University Law Center as an evening law student.

Education

  • Attending Georgetown University Law Center(J.D. expected December 2008)
  • M.S. in Microbiology and Immunology, University of Arkansas for Medical Sciences
  • B.S. in Biology, University of Washington, 1994

Admissions

  • U.S. Patent and Trademark Office

Mr. Toombs has nearly ten years' experience as a research scientist in the biotech./pharmaceutical industry. Prior to joining Sheppard Mullin he worked for Roche and Celera Genomics, where he was employed as Senior Scientist. Mr. Toombs' research at these organizations was focused on the development of diagnostic tests for pathogens and genetic disorders.

Articles

  • "Genetic variants on chromosome 9 are associated with late-onset Alzheimer's disease, variation in allele-specific gene expression, and differential apoptotic response," Y. Li, T.A. Toombs, A. Goate et al., presentation at the International Conference on Alzheimer's Disease, July 2006
  • "DAPK1 variants are associated with Alzheimer's disease and allele-specific expression," Y. Li, T.A. Toombs, A. Goate et al., Hum Molec Genet, July 17, 2006
  • "Quantitative multiplex TaqMan assays for colorectal cancer treatment selection markers," S. Kwok, T.A. Toombs, C. Christopherson et al., poster presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, January 2005
  • "Detection of groups M and O HIV-1, HCV and HBV by a multiplex polymerase chain reaction assay," K. Young, T.A. Toombs et al., poster presented at the Annual Meeting of the American Association of Blood Banks, 2000